RecruitingPhase 1NCT04699747
Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
Sponsor: Massachusetts General Hospital
Boston, MA
Multiple Sclerosis clinical trials in Boston, MA
24 recruiting multiple sclerosis studies with a site in Boston, MA.
RecruitingPhase 3NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
Boston, MA · Worcester, MA · +24 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Boston, MA · +49 more sites
RecruitingPhase 2NCT05104983
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Sponsor: Darcy Krueger
Boston, MA · +10 more sites
RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Boston, MA · Burlington, MA · Norfolk, MA · +106 more sites
RecruitingPhase 3NCT05877963
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Sponsor: TG Therapeutics, Inc.
Boston, MA · Foxborough, MA · +38 more sites
RecruitingPhase 2NCT07002034
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Sponsor: Reunion Neuroscience Inc
Boston, MA · Worcester, MA · +30 more sites
RecruitingNot applicableNCT06649955
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
Sponsor: PathMaker Neurosystems Inc.
Boston, MA
RecruitingPhase 3NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Sponsor: Novartis Pharmaceuticals
Boston, MA · Burlington, MA · Foxborough, MA · +41 more sites
RecruitingPhase 1 / Phase 2NCT06063850
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Sponsor: UniQure Biopharma B.V.
Boston, MA · +17 more sites
RecruitingPhase 3NCT06136728
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
Sponsor: MGH Institute of Health Professions
Boston, MA
RecruitingPhase not listedNCT05676099
TSC Biosample Repository and Natural History Database
Sponsor: National Tuberous Sclerosis Association
Boston, MA · +22 more sites
RecruitingPhase 2NCT06735248
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
Sponsor: ModernaTX, Inc.
Boston, MA · +7 more sites
RecruitingPhase not listedNCT01353547
Genes and Environment in Multiple Sclerosis
Sponsor: Columbia University
Boston, MA · +3 more sites
RecruitingPhase not listedNCT04603196
Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis
Sponsor: Beth Israel Deaconess Medical Center
Boston, MA
RecruitingPhase not listedNCT07011914
Care in Multiple Sclerosis (MS)
Sponsor: NYU Langone Health
Boston, MA · +5 more sites
RecruitingPhase 1NCT06665165
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Sponsor: Amylyx Pharmaceuticals Inc.
Boston, MA · +9 more sites
RecruitingPhase 1 / Phase 2NCT03207464
Molecular Imaging of NET Using [C-11]MRB-PET in MS
Sponsor: Brigham and Women's Hospital
Boston, MA
RecruitingPhase 1 / Phase 2NCT02649985
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
Sponsor: Brigham and Women's Hospital
Boston, MA
RecruitingEarly Phase 1NCT04634994
Assessment of Synaptic Density in MS
Sponsor: Brigham and Women's Hospital
Boston, MA
RecruitingPhase 4NCT07087106
Glucose Consumption in MS Using [F-18]FDG-PET
Sponsor: Brigham and Women's Hospital
Boston, MA
RecruitingPhase 2NCT06453694
Efgartigimod for the Treatment of Acute Optic Neuritis
Sponsor: Anastasia Vishnevetsky, MD, MPH
Boston, MA
RecruitingNot applicableNCT06554340
Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension
Sponsor: University of Massachusetts, Boston
Boston, MA
RecruitingPhase 2NCT06890923
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
Sponsor: Tiziana Life Sciences LTD
Boston, MA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.